Moffitt Cancer Center: Building New Traditions of Excellence
With a 30-year history of exponential growth, Moffitt Cancer Center is transforming cancer care through service, science and partnership. With a singular mission to contribute to the prevention and cure of cancer, the center is in the midst of an $800-million expansion, adding new patient beds, outpatient services, a hospital wing and facilities supporting the pioneering quests of world-renowned researchers as they unveil discoveries holding unprecedented potential to improve the lives of cancer patients.
Construction is crystallizing as part of Moffitt’s 10-year master plan, including important changes in the campus footprint to accommodate expansive patient growth.
Revolutionizing Cancer Research
Moffitt generates the highest-caliber cancer research in the nation. In the spotlight this year, the FDA is expected to make a final decision on approval of a new experimental immunotherapy developed and led by Moffitt scientists. CAR T-cell therapy extracts immune cells (T-cells) from the patient, genetically engineers the cells to fight cancer, and reintroduces the cells into the patient’s body. Researchers are using immunotherapies to develop a highly promising breast cancer vaccine for aggressive, early-stage cancers, too.
Life beyond cancer? We’re going way, way beyond.
Moffitt Cancer Center, with more than 5,400 employees, is fueling our local economy, generating more than $88 million a year in grants and public and private partnerships. Moffitt currently has more than 400 active interventional clinical trials — over 150 initiated by Moffitt researchers. Treating more than 56,000 outpatients last year, Moffitt boasts an economic impact of more than $2.1 billion annually and a passion for research that’s bringing more jobs, new technologies and better cancer care for everyone. That will ultimately make survival rates better for future patients.
Funding for Life-Saving Treatments
Moffitt plans to raise a projected $500 million for expansion while pursuing a $300-million bond supported by an increase in recurring funds from Florida’s cigarette tax.
Funding opportunities and planning for a new 250,000-square-foot research tower are in progress.